- Home
- CRBP vs REI Comparison
CRBP vs REI Comparison
Compare CRBP & REI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBP | REI |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.3M | 181.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRBP | REI |
|---|---|---|
| Price | $7.86 | $0.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $50.29 | N/A |
| AVG Volume (30 Days) | 492.2K | ★ 1.1M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $308,790,652.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $100.00 | $2.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.64 | $0.72 |
| 52 Week High | $20.56 | $1.55 |
Technical Indicators
Market Signals| Indicator | CRBP | REI |
|---|---|---|
| Relative Strength Index (RSI) | 28.92 | 53.73 |
| Support Level | $7.97 | $0.84 |
| Resistance Level | $8.54 | $0.89 |
| Average True Range (ATR) | 0.47 | 0.03 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 5.21 | 90.16 |
Price Performance
Historical ComparisonAbout CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.